Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
about
Mechanisms of the epithelial-to-mesenchymal transition in sea urchin embryosMembrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavageBrevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sitesMelanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagenMatrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Membrane-type MMPs enable extracellular matrix permissiveness and mesenchymal cell proliferation during embryogenesisPossible involvement of aminotelopeptide in self-assembly and thermal stability of collagen I as revealed by its removal with proteases.Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion.Metalloendoprotease cleavage triggers gelsolin amyloidogenesisCCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS-4 (Aggrecanase 1) Activity.TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processesConstraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells.Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activationSecreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion.New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.Matrix metalloproteinase collagenolysis in health and disease.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding.Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase.Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).Matrix metalloproteinase-13 (MMP-13, collagenase-3) is highly expressed in human tooth pulp.
P2860
Q26771613-51F27A39-C5E3-4BC3-8337-CE8AFDF051D7Q28115379-D690552E-B3E2-4DA5-8E16-5E7894963FD1Q28138661-CB414E99-8710-4387-990F-64F362BE60EAQ28208045-92926C7B-D165-4A75-A1F7-83DA5E5F9D53Q28214421-CA4B6FBE-DA90-467E-BF45-D7170C3DFC08Q28509350-3A1DD858-D8CD-442A-9429-4B7E84FDFB31Q30878642-67811916-F34D-4EEE-AE04-82D9F0FDB2D5Q33188043-E4DF847A-6079-476C-88F0-7B318A761C1CQ34099173-2EA3B920-67D5-430F-924D-0AC8AE26E6D8Q34324885-11E9089A-1DE4-497D-BB85-E9B455B0B3AAQ34464193-74B0A8EF-AE81-458A-9F82-A87E2D87C3B6Q34545340-8CE14F87-CC16-462F-B755-3DE00BB99F39Q36328263-3AD73473-2E66-4743-812C-233B7F5BB198Q36369835-FE16BB9F-B6F6-42DF-B2A7-5650407CD9CDQ36393553-8B021746-7D06-4B2F-A9C3-E049753C8DBFQ36402867-E4427A36-2100-4005-BA8F-BB457DFC0ABAQ37352283-72FB2F67-DE18-41D9-A03F-FB830A63642EQ37371709-34E61CBF-3C60-4341-9A88-8407F33CCA67Q37820192-45C2773D-FA8D-42FF-9FEE-C19C2CDCFAD6Q38431602-074181A1-F504-4BA7-A075-7CFE7AF42A63Q38870841-4871141B-C0D0-4323-B076-0B2F7BF6614CQ40513100-A005D74E-DC7D-44AC-B515-F21FD69D1917Q40688718-E90227F9-EBCC-48A6-AAF5-91425F387154Q42776385-999D2352-BCDD-4257-8762-D6A80E19BC92Q43559838-3E7CA066-C884-4FFA-BA42-AD12B4FF84F6Q44271086-67D54989-E26C-4DA7-95F5-4010E8066540Q46546852-11136060-FAE9-4515-B138-130C6EA74F3BQ54676032-BBC9AC05-D310-4B47-AE3D-BE6E784354B1
P2860
Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Characterization of a truncate ...... pe 3 matrix metalloproteinase.
@en
Characterization of a truncate ...... pe 3 matrix metalloproteinase.
@nl
type
label
Characterization of a truncate ...... pe 3 matrix metalloproteinase.
@en
Characterization of a truncate ...... pe 3 matrix metalloproteinase.
@nl
prefLabel
Characterization of a truncate ...... pe 3 matrix metalloproteinase.
@en
Characterization of a truncate ...... pe 3 matrix metalloproteinase.
@nl
P2093
P1433
P1476
Characterization of a truncate ...... ype 3 matrix metalloproteinase
@en
P2093
P304
P356
10.1046/J.1432-1327.1999.00459.X
P407
P577
1999-06-01T00:00:00Z